BiologicsDirect™ is a wholly owned subsidiary of CaseTech, LLC, a for profit Corporation based in Fort Lauderdale, Florida. Its board of directors consists of hospital and blood center based healthcare professionals active in the healthcare industry. Its leadership consists of:

Charles L. Rouault, M.D.
, is the CEO of BiologicsDirect™. Dr. Rouault is a 40 year veteran of the blood banking industry serving as the President and CEO of Community Blood Centers of South Florida, Inc. based in Fort Lauderdale, Florida. He oversaw the development of the blood center from a $3 million blood center in 1982 to $100 million in February, 2011 at the time of his retirement. Dr. Rouault then joined the faculty of the Department of Pathology of the University of Miami Miller School Of Medicine as a full professor and served as assistant medical director of the transfusion service at Jackson Memorial Hospital and medical director of the University of Miami Hospital and Clinics transfusion service. Dr. Rouault is board certified in Anatomic and Clinical Pathology, and Transfusion Medicine.
Alex Garcia, MBA, is the Executive Vice President of BiologicsDirect™. Prior to that, Alex was Director of Operations for the Counsel for Debt Solutions, a national credit management and debt settlement company. Prior to that, Alex started and served as President of 1st Interstate, LLC, a real estate finance and investment firm with title, mortgage and property acquisition divisions. Prior to that, he managed mortgage production offices for Centex Homes and First Town Mortgage. Alex Garcia has an extensive background in sales, marketing and management. Alex Garcia has a BA from Occidental College and an MBA from Florida Atlantic University.
561 Media, Inc. is a website and software development firm located in South Florida. 561 Media has been providing highly targeted and customized software and online web based solutions since 2007. With over 20 full time designers, developers and marketing specialists, 561 Media is capable of providing a wide array of development and support to the growing needs of the blood industry through the BiologicsDirect™ platform. Since inception, the 561 Media team has helped to develop and hone the functionality of this revolutionary new software, to ensure ease of use, user adoption and a streamlined workflow for the entire blood industry. 561 Media serves as the in-house development team and continues to improve and grow the core offerings of BiologicsDirect™, while offering ongoing support to the BiologicsDirect™ team and it's user base.

Blood Products

All Products FDA Approved

Red Blood Cells Leukopoor - A+ A- B+ B- AB+ AB- O+ O-

Red Blood Cells Non Leukopoor - A+ A- B+ B- AB+ AB- O+ O-

FFP 200 cc - A B O AB

Cryoprecipitate - A B O AB

Platelets Whole Blood Derived - A B O AB

Platelets Apheresis - A B O AB

Red Blood Cell Packages - Predetermined mix of ABO types

Specialty Products - RBCs & HLA Compatible Platelets